These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7248983

  • 1. Phase II study of vindesine in patients with metastatic breast cancer.
    Cobleigh MA, Williams SD, Einhorn LH.
    Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK, Raich PC, Fontana J, Subramanian VP, Rogers JS, Knost JA, Denning B.
    Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
    [Abstract] [Full Text] [Related]

  • 3. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.
    Yap HY, Blumenschein GR, Keating MJ, Hortobagyi GN, Tashima CK, Loo TL.
    Cancer Treat Rep; 1980 Sep; 64(2-3):279-83. PubMed ID: 7407762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE, Williams SD, Einhorn LH, Cobleigh MA.
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
    Wander HE, Nagel GA.
    Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP, Jones SE, Chester A.
    Cancer Treat Rep; 1980 Aug; 64(8-9):1001-3. PubMed ID: 7448818
    [Abstract] [Full Text] [Related]

  • 10. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
    Delva R, Pienkowski T, Tubiana N, Vanhoefer U, Longerey B, Douville I.
    Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
    [Abstract] [Full Text] [Related]

  • 11. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE, Camacho F, Wittes R, Young C.
    Cancer Treat Rep; 1980 May; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of esophageal cancer with vindesine: an open trial.
    Bezwoda WR, Derman DP, Weaving A, Nissenbaum M.
    Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
    [Abstract] [Full Text] [Related]

  • 13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 May; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 14. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [Abstract] [Full Text] [Related]

  • 15. Broad phase II study of vindesine.
    Valdivieso M, Bedikian AY, Bodey GP, Freireich EJ.
    Cancer Treat Rep; 1981 Sep; 65(9-10):877-9. PubMed ID: 7273021
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ, Aisner J, Carney DN, Van Echo DA, Ostrow SS, Ihde DC, Wiernik PH.
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.